Bell Investment Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$66.3K Sell
525
-70
-12% -$9.22K 0.01% 232
2026
Q1
$82.9K Buy
595
+3
+0.5% +$420 0.01% 187
2025
Q4
$72.7K Buy
592
+109
+23% +$13.2K 0.01% 198
2025
Q3
$53.6K Sell
483
-101
-17% -$11.5K 0.01% 233
2025
Q2
$64.7K Buy
584
+66
+13% +$7.02K 0.01% 207
2025
Q1
$58K Buy
518
+43
+9% +$4.44K 0.01% 204
2024
Q4
$43.9K Sell
475
-47
-9% -$4.23K 0.01% 238
2024
Q3
$43.8K Buy
522
+4
+0.8% +$305 0.01% 242
2024
Q2
$35.5K Sell
518
-516
-50% -$34.4K 0.01% 269
2024
Q1
$75.7K Sell
1,034
-29
-3% -$2.23K 0.01% 163
2023
Q4
$86.1K Buy
1,063
+153
+17% +$11.9K 0.02% 146
2023
Q3
$68.2K Buy
910
+412
+83% +$31.7K 0.02% 152
2023
Q2
$38.4K Sell
498
-19
-4% -$1.51K 0.01% 198
2023
Q1
$42.9K Sell
517
-3
-0.6% -$248 0.01% 182
2022
Q4
$44.6K Buy
520
+68
+15% +$5.38K 0.01% 181
2022
Q3
$28K Buy
452
+62
+16% +$3.91K 0.01% 206
2022
Q2
$24K Buy
+390
New +$24.1K 0.01% 237
2021
Q4
$29K Buy
403
+69
+21% +$4.75K 0.01% 234
2021
Q3
$23K Buy
+334
New +$23.5K 0.01% 256

Other funds holding GILD

Bell Investment Advisors's GILD Position: Q2 2026 in Review

Bell Investment Advisors reduced its Gilead Sciences (GILD) stake by 12% in Q2 2026, selling an estimated $9.22K and leaving 525 shares worth $66.3K. The position accounts for 0.01% of the portfolio, ranked #232.

Bell Investment Advisors first reported a position in GILD in Q3 2021 and has held it in 19 quarters since. The position peaked at $86.1K in Q4 2023. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Bell Investment Advisors held 525 shares of Gilead Sciences worth $66.3K as of Q2 2026.
  • Bell Investment Advisors sold 70 Gilead Sciences shares in Q2 2026, an estimated $9.22K.
  • Gilead Sciences made up 0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #232 holding.
  • Bell Investment Advisors first reported a position in Gilead Sciences in Q3 2021 and has held it in 19 quarters since.
  • Bell Investment Advisors's Gilead Sciences position peaked at $86.1K in Q4 2023.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.